Moderna
North America, Massachusetts, United States, Cambridge
Description
Moderna Therapeutics is a biotechnology company that specializes in vaccines and drug development.
Investor Profile
Moderna has backed more than 6 startups, with 0 new investments in the last 12 months alone. The firm has led 4 rounds, about 67% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Post Ipo Equity, Debt Financing rounds (top funding stages).
- Majority of deals are located in United States, Germany.
- Strong thematic focus on Biotechnology, Therapeutics, Artificial Intelligence (AI).
Stage Focus
- Series B (33%)
- Post Ipo Equity (33%)
- Debt Financing (17%)
- Series Unknown (17%)
Country Focus
- United States (67%)
- Germany (17%)
Industry Focus
- Biotechnology
- Therapeutics
- Artificial Intelligence (Ai)
- Machine Learning
- Health Care
- Hedge Funds
- Medical
- Genetics
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Moderna frequently co-invest with?
What are some of recent deals done by Moderna?
Find More Investors Like Moderna
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
